1.
Br J Urol
; 74(3): 375-6, 1994 Sep.
Artículo
en Inglés
| MEDLINE
| ID: mdl-7953271
2.
Ulster Med J
; 59(1): 90-2, 1990 Apr.
Artículo
en Inglés
| MEDLINE
| ID: mdl-2349756
3.
Ulster Med J
; 58(2): 198-9, 1989 Oct.
Artículo
en Inglés
| MEDLINE
| ID: mdl-2603277
Asunto(s)
Carcinoma de Células Renales/cirugía , Neoplasias Renales/cirugía , Neoplasias Pancreáticas/secundario , Neoplasias de la Tiroides/secundario , Carcinoma de Células Renales/diagnóstico , Femenino , Humanos , Persona de Mediana Edad , Neoplasias Pancreáticas/cirugía , Neoplasias de la Tiroides/cirugía
4.
J Hosp Infect
; 12(3): 215-9, 1988 Oct.
Artículo
en Inglés
| MEDLINE
| ID: mdl-2904462
RESUMEN
The results of a prospective randomized clinical trial to compare three dose regimens of mezlocillin with cefuroxime plus metronidazole for prophylaxis in emergency and elective colorectal surgery are reported. Severe wound infection occurred in five patients (10%) receiving mezlocillin and in four patients (7%) receiving cefuroxime and metronidazole. There were two episodes of septicaemia, each in the mezlocillin group. The total number of surgically related infections was less with cefuroxime plus metronidazole (n = 10) compared with mezlocillin (n = 17), but this was not statistically significant (P greater than 0.1).